Pharmacogenomics_Paediatric

Gene: DPYD

Amber List (moderate evidence)

DPYD (dihydropyrimidine dehydrogenase)
EnsemblGeneIds (GRCh38): ENSG00000188641
EnsemblGeneIds (GRCh37): ENSG00000188641
OMIM: 612779, Gene2Phenotype
DPYD is in 11 panels

2 reviews

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

I don't know

Phenotypes
Fluoropyrimidine

Publications

David Metz (Royal Children's Hospital)

Fluoropyrimidine (5-FU) Dosing
Capecitabine
Tegafur

Sources:
31038729
28262261
https://www.pharmgkb.org/guidelineAnnotation/PA166202721
Created: 14 Aug 2020, 4:20 a.m. | Last Modified: 21 Sep 2020, 12:05 a.m.
Panel Version: 0.50

Mode of inheritance
Other

Publications

Mode of pathogenicity
Other

History Filter Activity

14 Aug 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: dpyd has been classified as Amber List (Moderate Evidence).

14 Aug 2020, Gel status: 2

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: DPYD were changed from to Fluoropyrimidine

14 Aug 2020, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: dpyd has been classified as Amber List (Moderate Evidence).

14 Aug 2020, Gel status: 0

Created, Added New Source, Set mode of inheritance, Set publications, Set mode of pathogenicity

David Metz (Royal Children's Hospital)

gene: DPYD was added gene: DPYD was added to Pharmacogenomics_Paediatric. Sources: Other Mode of inheritance for gene: DPYD was set to Other Publications for gene: DPYD were set to 29152729 Mode of pathogenicity for gene: DPYD was set to Other